Cytomegalovirus Replication Within the Lung Allograft Is Associated With Bronchiolitis Obliterans Syndrome

Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation

(2013) Scott M. Palmer   ANNALS OF INTERNAL MEDICINE

Cytomegalovirus Pneumonitis Is a Risk for Bronchiolitis Obliterans Syndrome in Lung Transplantation

(2010) Laurie D. Snyder et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation

(2010) Camille N. Kotton et al.   TRANSPLANTATION

Immunobiology of Chronic Lung Allograft Dysfunction: New Insights from the Bench and Beyond

(2009) R. A. Shilling et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

(2009) A. Åsberg et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Cytomegalovirus Prevention in High-risk Lung Transplant Recipients: Comparison of 3- vs 12-Month Valganciclovir Therapy

(2009) Peter Jaksch et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report—2009

(2009) Jason D. Christie et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Lack of Association Between ß-herpesvirus Infection and Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients in the Era of Antiviral Prophylaxis

(2009) Oriol Manuel et al.   TRANSPLANTATION

Altered Levels of CC Chemokines During Pulmonary CMV Predict BOS and Mortality Post-Lung Transplantation

(2008) S. S. Weigt et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation

(2008) S. K. Arthurs et al.   CLINICAL INFECTIOUS DISEASES